Finance

Lists
EIKN:NASDAQ
Eikon Therapeutics Inc
$ 7.47
-0.40%
(-0.030) 1D
$ 7.47
0.00% (0.00)
After hours
Closed: 10-р сарын 9, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EIKN...
Open
$ 7.48
High
$ 7.82
Low
$ 7.25
Mkt. cap
404.61 сая
Avg. vol.
619.89 мян
Volume
288.69 мян
P/E ratio
0.14
52-wk high
$ 17.40
52-wk low
$ 7.02
EPS
$ 53.57
No. of employees
384
Open
$ 7.48
High
$ 7.82
Low
$ 7.25
Mkt. cap
404.61 сая
Avg. vol.
619.89 мян
Volume
288.69 мян
P/E ratio
0.14
52-wk high
$ 17.40
52-wk low
$ 7.02
EPS
$ 53.57
No. of employees
384
News stories
From web sources and news partners
About Eikon Therapeutics Inc
CEO-
Employees384
Founded2019
HeadquartersMillbrae, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to EIKN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for EIKN in the last 3 months.
Highest
Current $ 7.47
$ 32.00 (+328.38%)
Average
$ 31.00 (+314.99%)
Lowest
$ 29.00 (+288.22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Zemansky
Bank of America Securities
Buy
Maintained
$ 32.00
+328.4%
09/28/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
$ 32.00
+328.4%
08/17/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
$ 29.00
+288.2%
08/17/2026
Robert Driscoll
Wedbush
Sell
Maintained
$ 5.00
-33.1%
05/12/2026
Joseph Catanzaro
Mizuho Securities
Buy
Initiated
$ 26.00
+248.1%
03/02/2026
Last report
2026 оны 8-р сарын 13
Fiscal period
Q2 2026
-$ 1.63 / -$ 1.46
-11.54%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 6-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
66.19 сая
65.23 сая
70.05 сая
75.46 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.14 сая
17.73 сая
17.29 сая
17.93 сая
Operating expense
85.33 сая
82.96 сая
87.34 сая
93.39 сая
Total operating expenses
85.33 сая
82.96 сая
87.34 сая
93.39 сая
Operating income
-85.33 сая
-82.96 сая
-87.34 сая
-93.39 сая
Other non operating income
-2.00 мян
-9.00 мян
-1.00 мян.
-52.00 мян
EBT including unusual items
-105.21 сая
-79.66 сая
-82.96 сая
-88.41 сая
EBT excluding unusual items
-80.90 сая
-79.45 сая
-82.96 сая
-88.41 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-105.21 сая
-79.66 сая
-82.96 сая
-88.41 сая
Net profit margin
-
-
-
-
Earnings per share
-
-26.23
-2.46
-1.63
Interest and investment income
4.43 сая
3.52 сая
4.38 сая
5.04 сая
Interest expense
-
-
-
-
Net interest expenses
4.43 сая
3.52 сая
4.38 сая
5.04 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-81.12 сая
-77.57 сая
-82.12 сая
-88.26 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс